This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Care Winners & Losers: Hansen Medical

Shares of medical equipment makers fell Friday on more weak sales reports as hospitals continue to tighten capital spending while the economic outlook remains dim. Mountain View, Calif.-based Hansen Medical (HNSN - Get Report) said late Thursday it expects fourth-quarter sales between $7.1 million and $7.4 million, far below Wall Street expectations of $12.2 million.

The company, which sells medical robotic technology used with catheters, cited the economy's effect on customer spending.

Shares fell to $5.60 early in the trading session, marking their lowest point in more than two years.

The announcement follows Sunnyvale, Calif.-based Intuitive Surgical's (ISRG - Get Report) Wednesday announcement that fourth-quarter sales rose 22%. The figure also fell short of Wall Street expectations, with the maker of surgical devices citing weak hospital spending. The stock fell $8.79, or 8%, to $101.75 Friday.

Needham & Co. analyst Sameer Harish, meanwhile, downgraded shares of Sunnyvale, Calif.-based Cepheid (CPHD - Get Report) to "Hold" from "Buy," citing a slowdown in sales of the company's genetic testing systems.

"Due to the credit crisis, we believe hospitals may have pushed out GeneXpert and GeneXpert Infinity orders, which were expected to be shipped in the December quarter," he said, in a note to investors.

Cepheid shares fell 64 cents, or 6.6%, to $9.04.

Meanwhile, Needham colleague Ed Shenkan downgraded shares of Bedford, Mass.-based Hologic (HOLX - Get Report), which makes digital mammography systems, to "Hold" from "Buy," because of similar concerns. The stock fell 68 cents, or 6%, to $10.75 in afternoon trading, but earlier reached a more than three-year low of $10.34.

Elsewhere, shares of Palo Alto, Calif.-based Varian Medical Systems (VAR - Get Report), which makes radiation therapy systems, fell 3 cents to $32.38.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CPHD $26.02 0.89%
ISRG $614.11 -0.17%
HOLX $33.82 -0.21%
HNSN $4.03 -2.90%
VAR $81.18 -0.02%


Chart of I:DJI
DOW 17,694.78 +43.52 0.25%
S&P 500 2,055.41 +4.29 0.21%
NASDAQ 4,732.6950 +7.0560 0.15%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs